Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
about
Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition?Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of DiseaseAnalysis of the urine proteome via a combination of multi-dimensional approaches.Combinatorial peptide ligand libraries for the analysis of low-expression proteins: Validation for normal urine and definition of a first protein MAP.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.The primary glomerulonephritides: a systems biology approach.LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinomaUrinary protein selectivity in nephrotic syndrome and pregnancy: resurrection of a biomarker when renal biopsy is contraindicatedState-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics.Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Urine proteomics: the present and future of measuring urinary protein components in diseaseComparative proteomic analysis of urine and laser microdissected glomeruli in IgA nephropathy.Urinary proteomics: a tool to discover biomarkers of kidney diseases.Diagnostic potential for urinary proteomics.Urine biomarkers predict the cause of glomerular disease.Challenges of genomics and proteomics in nephrology.Urinary proteomics--a tool for biomarker discovery.Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.Proteomics - A New Approach in Biomedical StudiesUrinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.
P2860
Q33384709-3D6C0E29-8CEE-4155-A97E-6D66F333C50CQ33597457-93C0AA6A-273E-42A0-89D1-937BB7C77416Q34090618-F672C7A0-4B92-472C-80C5-C0158265163EQ34128102-A28D6807-239E-4164-B7F4-BF4AD2DCF252Q34187912-AC7529A7-01BC-4905-88E8-30534BC6BFABQ34462626-DE198F6D-3ABB-4D78-B9BA-A39A60E2980CQ34480669-9DFE6506-22D0-4D07-BBB0-3A029F25E504Q34664488-06C2BF42-E0F1-4535-88E4-7E7237273D58Q34836574-3507FE0C-58C0-42B4-BD65-2612B0DD291BQ35310597-62350DB6-DBF1-407E-AC9B-B51C3C0201D5Q35570959-4509D5A7-5827-46A5-94BE-B5C2689CCC75Q35862682-3E7A1EC2-74BE-42AC-98F2-69301A728449Q35929449-3557C6A8-380D-4E8C-A6C6-AC07CEA488DDQ36256303-327DDD8F-FBC2-4620-AED1-E6C8164CE2C5Q36731380-B52753A3-547B-4E30-9B60-C4F0662CFE02Q36745677-EDBBFA66-A0E8-48C8-BE7C-EFF3316D8CEDQ37323382-E0E2A55C-D3EA-4961-BD50-CF605D0E9F55Q37611029-2A6561D9-75D5-48F0-AA34-592E36E0942EQ37701845-7C92C3C0-F466-495B-8932-5567C276B062Q38613296-48014068-8482-4864-A7FF-F4F8316326FEQ42378620-E0A9D587-D40E-482E-804D-F13ABCF6A238Q47836059-CD9D01A1-250F-4C36-93B1-7B3DBC7DDFFD
P2860
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@ast
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@en
type
label
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@ast
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@en
prefLabel
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@ast
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@en
P2093
P356
P1433
P1476
Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
@en
P2093
Chang-Suk Kang
Chul-Woo Yang
Dong-Chan Jin
Eun-Hui Wang
Jung-Ho Cha
Kweon-Heang Lee
Mi-Ra Park
Yeong-Jin Choi
P304
P356
10.1002/PMIC.200500023
P577
2006-02-01T00:00:00Z